Amphenol Corporation (APH)
Official siteTECHNOLOGY • ELECTRONIC COMPONENTS • NYSE
Market Cap: $193.17B
Last updated: Nov 17, 2026 at 11:05 AM ET
Amphenol Corporation (APH) Earnings: Report Dates and Results
Amphenol (APH) is expected to report earnings on Jan 27, 2027. In the quarter ended Sep 30, 2026, Amphenol reported EPS of $0.80, above the $0.73 estimate. It beat the EPS estimate in each of the last 26 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
APH has an expected report date of Jan 27, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 14.4% below the $0.97 reported for the quarter ended Dec 31, 2025.
APH Earnings Call
The latest APH earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, APH beat 37 and matched 3. Revenue for the quarter ended Sep 30, 2026 was $10.23B, up 65.3% from $6.19B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.80 | $0.73 | $0.71 - $0.78 | +9.59% | Beat | -14.0% | 15 | 6 up, 0 down | Oct 28, 2026 | $10.23B |
| Jun 30, 2026 | $1.35 | $1.19 | $1.14 - $1.31 | +13.45% | Beat | +66.7% | 16 | 2 up, 0 down | Jul 29, 2026 | $8.76B |
| Mar 31, 2026 | $1.06 | $0.95 | $0.91 - $1.01 | +11.58% | Beat | +68.3% | 17 | 4 up, 0 down | Apr 29, 2026 | $7.62B |
| Dec 31, 2025 | $0.97 | $0.94 | $0.90 - $1.04 | +3.19% | Beat | +76.4% | 17 | 6 up, 2 down | Jan 28, 2026 | $6.44B |
| Sep 30, 2025 | $0.93 | $0.80 | $0.78 - $0.83 | +16.25% | Beat | +86.0% | 16 | 3 up, 0 down | Oct 22, 2025 | $6.19B |
| Jun 30, 2025 | $0.81 | $0.67 | $0.65 - $0.68 | +20.90% | Beat | +84.1% | 15 | N/A | Jul 23, 2025 | $5.65B |
| Mar 31, 2025 | $0.63 | $0.52 | $0.50 - $0.54 | +21.15% | Beat | +57.5% | 13 | 0 up, 0 down | Apr 23, 2025 | $4.81B |
| Dec 31, 2024 | $0.55 | $0.50 | $0.48 - $0.53 | +10.00% | Beat | +34.1% | 16 | 3 up, 1 down | Jan 22, 2025 | $4.32B |
| Sep 30, 2024 | $0.50 | $0.45 | $0.44 - $0.47 | +11.11% | Beat | +28.2% | 15 | 2 up, 1 down | Oct 23, 2024 | $4.04B |
| Jun 30, 2024 | $0.44 | $0.41 | $0.40 - $0.42 | +7.32% | Beat | +22.2% | 15 | 2 up, 0 down | Jul 24, 2024 | $3.61B |
| Mar 31, 2024 | $0.40 | $0.37 | $0.36 - $0.39 | +8.11% | Beat | +14.3% | 13 | 2 up, 1 down | Apr 24, 2024 | $3.26B |
| Dec 31, 2023 | $0.41 | $0.38 | $0.38 - $0.39 | +7.89% | Beat | +5.1% | 11 | 1 up, 0 down | Jan 24, 2024 | $3.33B |
| Sep 30, 2023 | $0.39 | $0.37 | $0.37 - $0.38 | +5.41% | Beat | -2.5% | 11 | 0 up, 0 down | Oct 25, 2023 | $3.20B |
| Jun 30, 2023 | $0.36 | $0.34 | $0.34 - $0.35 | +5.88% | Beat | -5.3% | 12 | 0 up, 1 down | Jul 26, 2023 | $3.05B |
| Mar 31, 2023 | $0.35 | $0.34 | $0.33 - $0.35 | +2.94% | Beat | +2.9% | 13 | 3 up, 0 down | Apr 26, 2023 | $2.97B |
| Dec 31, 2022 | $0.39 | $0.37 | $0.37 - $0.39 | +5.41% | Beat | +11.4% | 16 | 2 up, 1 down | Jan 25, 2023 | $3.24B |
| Sep 30, 2022 | $0.40 | $0.37 | $0.37 - $0.39 | +8.11% | Beat | +21.2% | 15 | 2 up, 0 down | Oct 26, 2022 | $3.30B |
| Jun 30, 2022 | $0.38 | $0.34 | $0.33 - $0.35 | +11.76% | Beat | +22.6% | 15 | 1 up, 0 down | Jul 27, 2022 | $3.14B |
| Mar 31, 2022 | $0.34 | $0.31 | $0.30 - $0.33 | +9.68% | Beat | +30.8% | 16 | 3 up, 0 down | Apr 27, 2022 | $2.95B |
| Dec 31, 2021 | $0.35 | $0.31 | $0.31 - $0.33 | +12.90% | Beat | +25.0% | 16 | 4 up, 0 down | Jan 26, 2022 | $3.03B |
| Sep 30, 2021 | $0.33 | $0.31 | $0.31 - $0.33 | +6.45% | Beat | +22.2% | 16 | 0 up, 0 down | Oct 27, 2021 | $2.82B |
| Jun 30, 2021 | $0.31 | $0.27 | $0.27 - $0.29 | +14.81% | Beat | +55.0% | 17 | N/A | Jul 28, 2021 | $2.65B |
| Mar 31, 2021 | $0.26 | $0.23 | $0.23 - $0.25 | +13.04% | Beat | +44.4% | 16 | N/A | Apr 28, 2021 | $2.38B |
| Dec 31, 2020 | $0.28 | $0.26 | $0.25 - $0.27 | +7.69% | Beat | +12.0% | 17 | N/A | Jan 27, 2021 | $2.43B |
| Sep 30, 2020 | $0.27 | $0.22 | $0.21 - $0.25 | +22.73% | Beat | +12.5% | 16 | N/A | Oct 21, 2020 | $2.32B |
| Jun 30, 2020 | $0.20 | $0.16 | $0.14 - $0.17 | +25.00% | Beat | -13.0% | 15 | N/A | Jul 22, 2020 | $1.99B |
| Mar 31, 2020 | $0.18 | $0.18 | $0.15 - $0.21 | 0.00% | In line | -18.2% | 14 | N/A | Apr 22, 2020 | $1.86B |
| Dec 31, 2019 | $0.25 | $0.23 | $0.22 - $0.23 | +8.70% | Beat | -3.8% | 15 | N/A | Jan 22, 2020 | $2.15B |
| Sep 30, 2019 | $0.24 | $0.22 | $0.22 - $0.22 | +9.09% | Beat | -4.0% | 13 | N/A | Oct 23, 2019 | $2.10B |
| Jun 30, 2019 | $0.23 | $0.23 | $0.23 - $0.24 | 0.00% | In line | 0.0% | 12 | N/A | Jul 24, 2019 | $2.02B |
| Mar 31, 2019 | $0.22 | $0.22 | $0.22 - $0.23 | 0.00% | In line | +4.8% | 11 | N/A | Apr 24, 2019 | $1.96B |
| Dec 31, 2018 | $0.26 | $0.24 | $0.24 - $0.25 | +8.33% | Beat | +18.2% | 12 | N/A | Jan 23, 2019 | $2.22B |
| Sep 30, 2018 | $0.25 | $0.23 | $0.23 - $0.24 | +8.70% | Beat | +13.6% | 13 | N/A | Oct 24, 2018 | $2.13B |
| Jun 30, 2018 | $0.23 | $0.21 | $0.21 - $0.22 | +9.52% | Beat | +15.0% | 13 | N/A | Jul 25, 2018 | $1.98B |
| Mar 31, 2018 | $0.21 | $0.20 | $0.20 - $0.21 | +5.00% | Beat | +16.7% | 13 | N/A | Apr 25, 2018 | $1.87B |
| Dec 31, 2017 | $0.22 | $0.20 | $0.20 - $0.21 | +10.00% | Beat | +15.8% | 13 | N/A | Jan 24, 2018 | $1.94B |
| Sep 30, 2017 | $0.22 | $0.20 | $0.20 - $0.20 | +10.00% | Beat | +22.2% | 13 | N/A | Oct 25, 2017 | $1.84B |
| Jun 30, 2017 | $0.20 | $0.18 | $0.18 - $0.19 | +11.11% | Beat | +25.0% | 13 | N/A | Jul 26, 2017 | $1.67B |
| Mar 31, 2017 | $0.18 | $0.17 | N/A | +5.88% | Beat | +20.0% | N/A | N/A | Apr 26, 2017 | $1.56B |
| Dec 31, 2016 | $0.19 | $0.18 | N/A | +5.56% | Beat | +18.8% | N/A | N/A | Jan 25, 2017 | $1.65B |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $3.34, up 76.7% from the year before. It was $0.68 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $3.34 | +76.7% |
| Dec 31, 2024 | $1.89 | +25.2% |
| Dec 31, 2023 | $1.51 | N/A |
| Dec 31, 2022 | $1.51 | +20.8% |
| Dec 31, 2021 | $1.25 | +34.4% |
| Dec 31, 2020 | $0.93 | N/A |
| Dec 31, 2019 | $0.94 | N/A |
| Dec 31, 2018 | $0.95 | +15.9% |
| Dec 31, 2017 | $0.82 | +20.6% |
| Dec 31, 2016 | $0.68 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 10,000 words across 16 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 10,317 | 16 | |
| 2026Q2 | Jun 30, 2026 | 5,495 | 16 | |
| 2026Q1 | Mar 31, 2026 | 5,820 | 15 | |
| 2025Q4 | Dec 31, 2025 | 1,887 | 16 | |
| 2025Q3 | Sep 30, 2025 | 9,810 | 16 | |
| 2025Q2 | Jun 30, 2025 | 4,137 | 15 | |
| 2025Q1 | Mar 31, 2025 | 9,084 | 17 | |
| 2024Q4 | Dec 31, 2024 | 8,743 | 16 |
2026Q3 Earnings Call
Opening remarks
Craig A. Lampo CFO Thank you very much. Good afternoon, everyone. This is Craig Lampo, Amphenol's CFO, and I am here together with Adam Norwitt, our Chairman and CEO. We would like to welcome you to our third quarter 26 conference call. Our third quarter 26 results were released this morning. I will provide some financial commentary, and then Adam will give an overview of the business and current market trends. Then we will take your questions. As a reminder, during the call, we may refer to certain non-GAAP financial measures and make certain forward-looking statements. So please refer to the relevant disclosures in our press release for further information. In addition, as a result of our recently announced 2-for-1 stock split effective on 09/03/2026, all share and per-share data discussed on this earnings call will reflect the split. The company closed the third quarter of 26 with record sales of $10.2 billion and GAAP and adjusted diluted EPS of $0.79 and $0.80, respectively. Third quarter sales were up 65% in U.S. dollars and in local currencies, and 37% organically compared to the third quarter of 25. Sequentially, sales were up 17% in U.S. dollars and in local currencies and up 16% organically. Adam will comment further on trends by market in a few minutes. Orders in the quarter were a record $12.17 billion, up a strong 99% compared to the third quarter of 25 and up 13% sequentially, resulting in another very strong book-to-bill ratio of 1.19 to 1. This impressive book-to-bill was driven by robust bookings in most of our end markets, with positive book-to-bill in all but one of our end markets this quarter. GAAP and adjusted operating income were both approximately $3 billion in the quarter, and GAAP and adjusted operating margins were 29.5% and 29.7%, respectively. On an adjusted basis, operating margin increased by a strong 22 basis points from the prior-year quarter and declined a modest 10 basis points sequentially. The year-over-year increase in adjusted operating margin was primarily driven by robust operating leverage on the significantly higher sales volumes, which more than offset the margin-dilutive impact of recent acquisitions. On a sequential basis, the slight decrease in adjusted operating margin was driven by a meaningfully larger benefit from tariff recoveries in the second quarter. Excluding these benefits, our adjusted operating margin improved by approximately 70 basis points, reflecting strong conversion on higher sales levels as well as continued progress on profitability improvement at recent acquisitions, and particularly CommScope. I am very proud of the company's operating margin performance in the third quarter, which reflects continued strong execution by our team.
Frequently Asked Questions About APH
When is Amphenol's next earnings date?
Amphenol's next earnings report is expected for Jan 27, 2027.
Did APH beat earnings estimates last quarter?
Yes. Amphenol reported EPS of $0.80 for the quarter ended Sep 30, 2026, above the $0.73 estimate, a 9.59% surprise.
What EPS do analysts expect from APH next quarter?
The consensus EPS estimate for Amphenol for the quarter ending Dec 31, 2026 is $0.83 from 16 analysts, with estimates from $0.76 to $0.88.
How often does APH beat earnings estimates?
Amphenol beat the EPS estimate in each of the last 26 quarters, with an average surprise of +11.24%.
APH pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts